Regenerative Medicine News
NIH-CRM Awards Cellular Dynamics up to $7 Million to Produce Human Induced Pluripotent Stem Cells and Differentiated Tissue Cells
October 24, 2012 - (CDI) - "The National Institutes of Health Center for Regenerative Medicine (NIH-CRM) has awarded Cellular Dynamics International, Inc. (CDI), the world's largest commercial producer of human induced pluripotent stem (iPS) cell lines and tissue cells, a contract to provide human iPS cell lines and terminally differentiated tissue cells from normal or specified patient populations. The contract is worth up to $7.0 million for the three year life of the agreement." Read Full Article
Posted on
13-Nov-12
by Gallerno, Jacob
Tags:
Science and Industry News
Trackback Url
|
Link to this post
| Bookmark this post with:
